![Arno Hartmann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Arno Hartmann
Director/Board Member at
BioVascular, Inc.
Profile
Arno Hartmann is currently a Director at Tioga Pharmaceuticals, Inc. and BioVascular, Inc. He was formerly a Director at Vaximm AG.
He received his undergraduate and doctorate degrees from the University of Giessen in 1987.
Arno Hartmann active positions
| Companies | Position | Start |
|---|---|---|
BioVascular, Inc.
 BioVascular, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and devices for control of intimal hyperplasia associated with vascular procedures | Director/Board Member | - |
Tioga Pharmaceuticals, Inc.
 Tioga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of gastrointestinal diseases | Director/Board Member | - |
Former positions of Arno Hartmann
| Companies | Position | End |
|---|---|---|
Vaximm AG
 Vaximm AG Miscellaneous Commercial ServicesCommercial Services Develops immunotherapies for cancer treatment | Director/Board Member | - |
Training of Arno Hartmann
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
20
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Tioga Pharmaceuticals, Inc.
Tioga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of gastrointestinal diseases | Health Technology |
University of Giessen
 University of Giessen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioVascular, Inc.
BioVascular, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and devices for control of intimal hyperplasia associated with vascular procedures | Health Technology |
Vaximm AG
Vaximm AG Miscellaneous Commercial ServicesCommercial Services Develops immunotherapies for cancer treatment | Commercial Services |
- Stock Market
- Insiders
- Arno Hartmann
